{"id":14673,"date":"2012-03-13T01:30:00","date_gmt":"2012-03-13T00:30:00","guid":{"rendered":"http:\/\/www.fedaiisf.it\/usa-respinto-accordo-jj-per-marketing-scorretto-di-risperdal\/"},"modified":"2012-03-13T01:30:00","modified_gmt":"2012-03-13T00:30:00","slug":"usa-respinto-accordo-jj-per-marketing-scorretto-di-risperdal","status":"publish","type":"post","link":"https:\/\/www.fedaiisf.it\/en\/usa-respinto-accordo-jj-per-marketing-scorretto-di-risperdal\/","title":{"rendered":"Usa: J&amp;J agreement rejected for incorrect marketing of Risperdal"},"content":{"rendered":"<p><font size=\"3\"><font face=\"Times New Roman\"><\/font><\/font><\/p>\n<p align=\"right\"><font size=\"3\"><font face=\"Times New Roman\"><img loading=\"lazy\" decoding=\"async\" style=\"padding-bottom: 8px; width: 380px; padding-right: 8px; height: 303px; padding-top: 8px\" id=\"il_fi\" alt=\"\" width=\"450\" height=\"360\" src=\"http:\/\/www.cchrint.org\/wp-content\/uploads\/2012\/02\/imgname-first_generic_risperdal_risperidone_fdaapproved-50226711-Risperdal1.jpg\" \/><\/font><\/font><\/p>\n<p><font size=\"3\"><font face=\"Times New Roman\">I procuratori federali Usa hanno respinto l&#8217;accordo da 1 mld di dollari proposto da&nbsp;Johnson &amp; Johnson (J&amp;J) per risolvere le accuse secondo cui&nbsp;l&#8217;azienda avrebbe promosso&nbsp;l&#8217;antipsicotico Risperdal (risperidone) per usi non approvati.<span style=\"font-family: &quot;Verdana&quot;,&quot;sans-serif&quot;; color: black; font-size: 9pt\"><\/p>\n<p><\/span><\/font><\/font><\/p>\n<p style=\"margin: 0cm 0cm 10pt\" class=\"MsoNormal\"><strong><span style=\"line-height: 115%; font-family: &quot;Verdana&quot;,&quot;sans-serif&quot;; color: black; font-size: 9pt; font-weight: normal; mso-bidi-font-family: 'Times New Roman'; mso-bidi-theme-font: minor-bidi; mso-ansi-language: EN-US; mso-bidi-font-weight: bold\" lang=\"EN-US\">(The Wall Street Journal online &#8211; 09\/03\/2012)&nbsp;&nbsp; <img","protected":false},"excerpt":{"rendered":"<p>I procuratori federali Usa hanno respinto l&#8217;accordo da 1 mld di dollari proposto da&nbsp;Johnson &amp; Johnson (J&amp;J) per risolvere le accuse secondo cui&nbsp;l&#8217;azienda avrebbe promosso&nbsp;l&#8217;antipsicotico Risperdal (risperidone) per usi non approvati. (The Wall Street Journal online &#8211; 09\/03\/2012)&nbsp;&nbsp;<\/p>","protected":false},"author":1,"featured_media":9846,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[90],"tags":[],"class_list":["post-14673","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-fedaiisf-archivio-storico"],"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14673","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/comments?post=14673"}],"version-history":[{"count":0,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/posts\/14673\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media\/9846"}],"wp:attachment":[{"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/media?parent=14673"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/categories?post=14673"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fedaiisf.it\/en\/wp-json\/wp\/v2\/tags?post=14673"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}